Announcements

Robert C. Murphy, an officer and director of Snap Inc, filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 2,000,000 shares of Snap common stock through Wells Fargo Clearing Services on behalf of The Wayne Manor Revocable Trust.

Director Robert E. Diamond Jr. filed a Form 4 on November 9, 2026, disclosing the acquisition of 17,123 restricted stock units in Hyperliquid Strategies Inc (NASDAQ:PURR) on November 5, 2026.

Peter Kampian, a newly appointed director of Greenlane Holdings, Inc., filed an initial statement of beneficial ownership with the SEC on November 9, 2026, reporting no securities beneficially owned as of the event date of October 27, 2026.

Kyle Clark, an officer of BETA Technologies, Inc., filed a Form 144 notice of proposed sale on November 9, 2026, disclosing plans to sell 10,000 shares of common stock on the NYSE under Rule 144 of the Securities Act of 1933.

Martin Wilson, General Counsel of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), filed a Form 4 on November 9, 2026, disclosing the sale of 53,389 shares of common stock on November 5, 2026, to cover tax withholding obligations related to vesting restricted stock units.

Teva Pharmaceutical Industries Ltd's Executive Vice President of European Commercial, Richard Daniell, filed a Form 144 notice of proposed sale of 25,000 ordinary shares on November 9, 2026, with the sale to be executed through Citigroup Global Markets Inc. on NYSE.

Gartner, Inc. officer Yvonne Genovese filed a Form 144 notice of proposed sale of 524 shares of Gartner common stock, submitted on November 9, 2026.